Inhalable Drug Delivery Devices Market is Expected to Reach $41.96 bn by 2026
The Inhalable Drug Delivery Devices Market was valued at US$30.43 billion in the year 2018 and is estimated to reach US$41.96 billion by 2026, at a CAGR of 4.1%. Inhalation route is one of the effective and quicker way of drug administration directly to the lungs, for treating acute and chronic pulmonary disorders such as chronic obstructive pu... Read More
Dialysis Devices Market is Expected to Reach $27.88 bn by 2026
The Dialysis Devices Market was valued at US $17.99 billion in the year 2018 and is estimated to reach US $27.88 billion by 2026, at a CAGR of 5.65% Dialysis is the treatment method for the patients with end-stage renal disease (ESRD) or kidney injury until they get kidney transplant and, for lifetime in case of transplant ki... Read More
Obesity Treatment Market is Expected to Reach $14.66 bn by 2026
The Global Obesity Treatment Market was valued at US$5.55 billion in the year 2018 and is estimated to reach US$14.66 billion by 2026, at a CAGR of 12.92%. Obesity can be denoted as a condition where excessive fat accumulation is seen in the body that leads to associated health risks such as cardio vascular diseases, diabetes, orthopedic disord... Read More
Sinusitis Treatment Market is Expected to Reach $3.7 bn by 2026
The Sinusitis Treatment Market was valued at US $1.9 billion in the year 2018 and is estimated to reach US $3.7 billion by 2026, at a CAGR of 8.68%. Sinusitis results from inflammation of sinus lining, air cavities within passage of nose usually caused by infection (bacteria, and viruses), chemical, allergies, and autoimmune problems. Symptoms ... Read More
Allergic Rhinitis Treatment Market is Expected to Reach $9.66 bn by 2026
The Allergic Rhinitis Treatment Market was valued at US $6.95 billion in the year 2018 and is estimated to reach US $9.66 billion by 2026, at a CAGR of 4.20%. Allergic Rhinitis is inflammation caused inside the nose by allergen, also called as hay fever. Allergic Rhinitis develops when body’s immune system becomes sensitized and overreact... Read More
Uterine Fibroids Treatment Market is Expected to Reach $1.37 bn by 2026
The Uterine Fibroids Treatment Market was valued at US $1.08 billion in the year 2018 and is expected to reach US $1.37 billion by 2026, with a CAGR of 2.97%. Uterine Fibroids also called as uterine leiomyomas are benign tumors that develop from smooth muscle cells or fibrous connective tissue in the uterus. Symptoms of Uterine fibroids i... Read More
Endoscopes Market is Expected to Reach $17.9 bn by 2026
The Endoscopes Market was valued at US$9.32 billion in the year 2018 and is estimated to reach US$17.9 billion by 2026, with a CAGR of 8.5%. Endoscopy is a non-surgical or a minimally invasive procedure or that involves the insertion of a long tube known as an endoscope into our body either through mouth or anus for visualization or for conduct... Read More
Macular Edema Treatment Market is Expected to Reach $4.08 bn by 2026
The Macular edema Treatment Market was valued at US $3.16 billion in the year 2018 and is estimated to reach US $4.08 billion by 2026, at a CAGR of 3.22%. Macular Edema occurs due to abnormal leakage and accumulation of fluid in the macula from damaged blood vessels adjacent to retina. The symptoms of macular edema include blurry or distor... Read More
Hemostasis And Tissue Sealing Agents Market is Expected to Reach $4.29 bn by 2026
The Hemostasis and Tissue Sealants Market was valued at US $2.12 billion in the year 2018 and is estimated to reach US $4.29 billion by 2026, at a CAGR of 9.21%. Tissue sealants are glue-like substances used to bind the tissue after a surgical procedure or after an injury to prevent excessive blood loss. Hemostasis is the principal clotting mec... Read More
Prostate Cancer Treatment Market is Expected to Reach $11.88 bn by 2026
The Prostate Cancer Treatment Market was valued at US$8.26 billion in the year 2018 and is estimated to reach US$11.88 billion by 2026, at a CAGR of 4.65%. Prostate cancer is a cancer of the prostate gland, 99% is of adenocarcinoma type developing in the gland cells and the rest 1% being sarcoma type arising in the tissues and distinguishable i... Read More